Paul Zhang, M.D., Ph.D., ABIHM

Dr. Paul Zhang, a distinguished physician-scientist, is the esteemed founder of the Omega Precision Oncology Clinic and the Institute of Integrative BioOncology.

With over two decades of experience, Dr. Zhang has made significant contributions to both oncology and integrative medicine, solidifying his reputation as a leader in the field.

Dr. Zhang’s medical journey is marked by an impressive array of qualifications. He is board-certified in Medical Oncology and Integrative Holistic Medicine, having received his clinical oncology training at the prestigious Yale University. His thirst for knowledge led him to pursue a Research Fellowship at the renowned Memorial Sloan Kettering Cancer Center (MSKCC) in New York, where he further honed his expertise. Additionally, Dr. Zhang expanded his skill set with training in Medical Acupuncture at the esteemed Helms Institute at Stanford University.

Dr. Zhang’s journey to becoming a respected medical oncologist and cancer researcher was profoundly influenced by his mentors, Dr. Joseph Michaeli, MD, and Dr. Nancy Berliner, MD. Under the mentorship of Dr. Michaeli, a distinguished clinician-scientist and former Associate Professor of Medicine at Cornell University and MSKCC, Dr. Zhang gained invaluable insights into cancer stem cells and clinical research, which served as the cornerstone of his career. Furthermore, guidance from Dr. Berliner, Professor of Medicine at Harvard Medical School and Chief of the Division of Adult Hematology, provided Dr. Zhang with a comprehensive understanding of cancer management, while also enriching his knowledge in hematopoiesis. These mentorship experiences played a pivotal role in shaping Dr. Zhang’s expertise and approach to oncology, laying a solid foundation for his subsequent accomplishments in the field.

Specializing in the medical treatment of solid tumors, including gastroenterological, lung, prostate, and breast cancers, Dr. Zhang’s dedication to his patients is unwavering. As a member of esteemed organizations such as the American Association for Cancer Research (AACR), the Society of Integrative Oncology(SIO) and the Society for Immunotherapy of Cancer, he advocates strongly for evidence-based comprehensive and integrative approaches to treatment and health restoration.

Dr. Zhang’s impact on cancer research is significant. He has pioneered breakthroughs in understanding cancer stem cells and exploring the off-label use of medicine in cancer treatment. Collaborating with research scientists from the Texas A&M Institute and MD Anderson Cancer Center, Dr. Zhang and his team embarked on extensive investigations aimed at identifying optimal combinations of off-label medicines to target cancer stem cells. Through innovative approaches like high-throughput screening, supported by the Duncan Scholarship grant, they sought to eradicate cancer stem cells effectively. Dr. Zhang’s expertise also spans molecular cancer biology and cancer metabolism, where his groundbreaking insights continue to pave the way for novel approaches to cancer treatment

In addition to his clinical and research endeavors, Dr. Zhang has distinguished himself in academia. He is certified in both Conventional Medical Oncology and Integrative Medicine, a rare feat that speaks to his breadth of knowledge and expertise. Named as one of the Top Doctors in Oncology, Dr. Zhang’s reputation for excellence precedes him. As a Principal Investigator, Dr. Zhang has conducted numerous clinical trials focusing on cancer vaccines, immunotherapies, and high-dose vitamins, contributing significantly to the advancement of cancer treatment modalities. His academic prowess is further evidenced by his role as a former Assistant Professor of Medicine at Baylor College of Medicine in Houston. Dr. Zhang’s scholarly achievements extend beyond the confines of the classroom and laboratory. He has published as a first author in prestigious medical journals such as Proceedings of the National Academy of Sciences of the United States of America (PNAS)  and has presented his research at numerous national and international conferences. Furthermore, Dr. Zhang serves as one of the editors of the textbook “Tumor Board Review,” solidifying his status as a thought leader in his field.

Currently, Dr. Zhang serves as the supervising physician at the Omega Precision Oncology Clinic in Houston, where he provides expert guidance and care to patients seeking integrative cancer treatment. Additionally, he holds the positions of Medical Director and Staff Oncologist at the Savoy Cancer Center, contributing his wealth of knowledge and experience to standard cancer care. Moreover, Dr. Zhang serves as a Consulting Physician at the Care Oncology Clinic USA, where he continues to offer his expertise in off-label medicines and integrative oncology to enhance patient outcomes.